TTY Biopharm Company Limited (TPEX:4105)
77.00
+1.10 (1.45%)
Jun 6, 2025, 1:30 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Cancer Drugs | 2.40B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Cancer Drugs Growth | -1.21% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Anti-infective Drugs | 1.22B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Anti-infective Drugs Growth | 20.35% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Investment | 1.12B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Investment Growth | 37.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Export Sales and OEM | 936.49M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Export Sales and OEM Growth | 17.55% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medical Insurance | 186.34M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medical Insurance Growth | -51.71% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 35.23M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | -46.16% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Critical Care | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Critical Care Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Cardiovascular and Gastrointestinal Drugs | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Cardiovascular and Gastrointestinal Drugs Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Taiwan | 5.12B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Taiwan Growth | 5.78% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Countries | 391.78M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Countries Growth | -1.73% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
America | 381.29M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
America Growth | 43.50% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|